Filter
9099
Filtered Results: 9099
Text search:
country
health
report
Featured
Recommendations
670
New Publications
2537
Language
Document type
No document type
5322
Studies & Reports
1755
Guidelines
866
Manuals
375
Strategic & Response Plan
330
Fact sheets
163
Situation Updates
116
Training Material
115
Resource Platforms
25
Infographics
14
Brochures
12
Online Courses
4
Dashboards/Maps
1
App
1
Countries / Regions
India
380
Global
368
Kenya
320
Ethiopia
220
Sierra Leone
212
Uganda
201
Liberia
195
Western and Central Europe
185
Nigeria
184
Nepal
180
Myanmar / Burma
173
South Africa
164
Zambia
148
Rwanda
146
Latin America and the Carribbean
138
Malawi
137
Bangladesh
135
Ghana
128
Africa
127
Syria
126
Tanzania
126
Ukraine
113
Congo, Democratic Republic of
91
Philippines
76
Namibia
73
South Sudan
71
Lesotho
71
Senegal
66
Eastern Europe
66
Zimbabwe
65
Mozambique
65
Cambodia
61
Indonesia
59
Asia
59
Venezuela
59
Guinea
58
South–East Asia Region
58
Yemen
57
Haiti
55
Burkina Faso
50
West and Central Africa
47
Botswana
44
Cameroon
43
East and Southern Africa
42
Brazil
38
Russia
38
Germany
37
Pakistan
36
Colombia
36
Afghanistan
34
Middle East and North Africa
33
Eswatini/ Swaziland
31
Eastern Europe and Central Asia
31
Central African Republic
27
Benin
26
Lebanon
25
Madagascar
25
Mali
24
Jordan
23
Somalia
22
Sudan
21
Thailand
20
Tajikistan
19
Côte d’Ivoire / Ivory Coast
16
Peru
16
Western Pacific Region
16
China
15
Albania
15
Moldova
15
Vietnam
15
Iraq
13
Paraguay
13
Sri Lanka
12
Georgia
12
USA
11
Togo
11
Turkey
11
Argentina
11
Laos
11
Papua New Guinea
10
North Macedonia
10
Niger
9
Ecuador
9
Chile
9
Bolivia
8
Greece
8
Libya
8
Angola
8
Palestine
8
Southern Africa
8
Iran
8
Kyrgyzstan
8
North America
8
Guinea-Bissau
7
Egypt
7
Burundi
7
Poland
7
Armenia
7
Chad
6
Hungary
6
Mexico
6
Bhutan
6
Romania
6
Jamaica
6
Gambia
5
El Salvador
5
Timor Leste/ East Timor
5
Kazakhstan
5
Portugal
5
Spain
5
Malaysia
4
Serbia
4
Honduras
4
Turkmenistan
4
Tunisia
4
United Kingdom
4
Belarus
4
Morocco
3
Saudi Arabia
3
Croatia
3
Guatemala
3
Italy
3
Djibouti
3
Uzbekistan
3
Japan
3
France
3
Mauritius
3
Bosnia and Herzegovina
3
Mauritania
2
Singapore
2
Dominican Republic
2
Nicaragua
2
Congo-Brazzaville
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Gabon
2
Azerbaijan
2
Israel
2
Ireland
1
Vanuatu
1
Other region
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3706
Clinical Guidelines
542
Public Health
469
Women & Child Health
443
Key Resources
399
Capacity Building
142
Pharmacy & Technologies
77
Annual Report MEDBOX
3
Toolboxes
HIV
709
COVID-19
670
Mental Health
635
TB
457
Disability
382
Planetary Health
334
Conflict
300
Ebola
268
Rapid Response
265
AMR
254
NTDs
203
Caregiver
198
Refugee
192
Global Health Education
154
Pharmacy
150
NCDs
147
Health Financing Toolbox
114
Natural Hazards
113
Polio
54
Cholera
52
Zika
51
Specific Hazards
38
Social Ethics
21
Typhoon
7
Health Financing
3
South Sudan
2
BMJ is offering a range of free online resources to support researchers, doctors, nurses, and other healthcare professionals to understand and respond to the global health emergency caused by the novel coronavirus (2019-nCoV).
The free online res...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans ...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibioti...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
Many migrants find themselves with limited access, if any, to information about risks, prevention measures, health care and other essential services. Migrants in transit, those in need of international protection or without legal status are likely t...
Five months after the beginning of the desert locust upsurge in the Greater Horn of Africa and Yemen, and four months since the launch of the response plan (24 January 2020) a total of USD 130 million have been mobilized in the region.
As described in the recently published Food and Agriculture Org...
The COVID-19 pandemic has affected everyone, including key populations at higher risk of HIV. And the gains made against other infectious diseases, including HIV, are at risk of being reversed as a result of disruptions caused by COVID-19. This is the background to a new ... published by FHI 360, in collaboration with UNAIDS, which gives advice on how to minimize the impacts of COVID-19 on key populations.
The creaNon of ‘friendly spaces’ for women and girls has been a key
strategy in the protecNon and empowerment of women 1 and girls in South
Sudan since conflict re-erupted in the country in December 2013. This
document provides guidance on th...
This practical guidance is designed to assist programme specialists to implement COVID19 RCCE activities for and with refugees, IDPs, migrants and host communities vulnerable to the pandemic. The guidance highlights key challenges and barriers faced by these people in accessing COVID19 ...-related information and presents key considerations and recommendations for planning and implementing RCCE activities. The document can be adapted to countries’ specific context and aligned with national response plans for COVID-19 and national RCCE plans.
The outbreak of COVID-19 comes with unpredictable primary and secondary impacts on vulnerable and food-insecure populations across the world. Mortality and morbidity appear to be most acute for elderly people, and those with underlying health...
In Israel, as in other countries, the COVID-19 outbreak highlights existing structural inequities,which compromise the health of some migrant groups. The Israeli case also demonstrate show strong NGOs successfully advocate for the protection of migr...
COVID-19 has resulted in an unprecedented global crisis. As the pandemic spreads and countries around the world continue to struggle to contain its health and socio-economic consequences, UNRWA is issuing a new humanitarian appeal from August throug...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assuran...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
These guidelines were developed as part of Kenya's fast-track plan to end AIDS among adolescents and young people. Based on research into adolescent and young key populations in Kenya and elsewhere, they outline a package of HIV prevention services, and emphasize the need to combine biobehavioural i...
Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m...
Volumen 5 / Número 1 , 1025-1028 • http://www.revistabionatura.com
To describe the behavior of Tuberculosis/Human Immunodeficiency Virus co-infection in a cohort of people affected by sensitive Tuberculosis in Ecuador from 01 January 2010 to 31 December 2015. Results: The percentage of co...
Because of the limited access to more powerful diagnostic tools, there is a paucity of data regarding the burden of fungal infections in Burkina Faso. The aim of this study was to estimate the incidence and prevalence of serious fungal infections in this sub-Saharan .... We primarily used the national demographic data and performed a PubMed search to retrieve all published papers on fungal infections from Burkina Faso and its surrounding West African countries. Considering the prevalence of HIV infection (0.8% of the population) and a 3.4% incidence of cryptococcosis in hospitals, it is estimated that 459 patients per year develop cryptococcosis. For pneumocystosis, it is suggested that 1013 new cases occur every year. Taking into account the local TB frequency (population prevalence at 0.052%), we estimate the prevalence of chronic pulmonary aspergillosis at 1120 cases. Severe forms of asthma with fungal sensitization and allergic bronchopulmonary aspergillosis are estimated to affect 7429 and 5628 cases, respectively. Vulvovaginal candidiasis may affect 179,000 women, and almost 1,000,000 children may suffer from tinea capitis. Globally, we estimate that roughly 1.4 million people in Burkina Faso (7.51% of the population) suffer from a serious fungal infection. These data should be used to drive future epidemiological studies, diagnostic approaches, and therapeutic strategies.
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
w...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This ... updates that assessment of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
